https://www.selleckchem.com/pr....oducts/Lapatinib-Dit
er risk of developing severe events during hospitalization. Conclusions Patients with CVD history tend to have adverse clinical outcomes after being infected with SARS-COV-2. Decreased lymphocyte counts and increased blood urea nitrogen levels may be risk factors for adverse outcomes in patients with COVID-19, and had CVD.[This corrects the article DOI 10.3389/fpsyg.2021.731901.].Recently, researchers have shown an increased interest in achievement goal orientation correlates. What is not yet clear is the detailed relations
Like
Comment
Share
